Shares of Spire Healthcare Group (LON:SPI) hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 204.80 ($2.87) and last traded at GBX 206 ($2.89), with a volume of 1718198 shares trading hands. The stock had previously closed at GBX 209.20 ($2.94).
A number of equities analysts have issued reports on the stock. JPMorgan Chase restated a “neutral” rating and set a GBX 339 ($4.76) target price on shares of Spire Healthcare Group in a research report on Thursday, January 4th. Liberum Capital restated a “hold” rating and set a GBX 270 ($3.79) target price on shares of Spire Healthcare Group in a research report on Tuesday, January 16th. Numis Securities restated an “add” rating and set a GBX 296 ($4.15) target price on shares of Spire Healthcare Group in a research report on Tuesday, January 16th. Jefferies Group upgraded shares of Spire Healthcare Group to a “buy” rating and lifted their target price for the stock from GBX 259 ($3.64) to GBX 290 ($4.07) in a research report on Wednesday, January 17th. Finally, Barclays assumed coverage on shares of Spire Healthcare Group in a research report on Friday, February 2nd. They set an “equal weight” rating and a GBX 270 ($3.79) target price for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of GBX 283.17 ($3.97).
Spire Healthcare Group (LON:SPI) last announced its earnings results on Friday, March 2nd. The company reported GBX 14.40 ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of GBX 14.60 ($0.20) by GBX (0.20) ($0.00). The business had revenue of £931.70 million for the quarter. Spire Healthcare Group had a return on equity of 1.71% and a net margin of 1.85%.
The firm also recently announced a dividend, which will be paid on Tuesday, June 26th. Shareholders of record on Thursday, May 31st will be given a dividend of GBX 2.50 ($0.04) per share. The ex-dividend date of this dividend is Thursday, May 31st. This represents a yield of 1.12%. This is a boost from Spire Healthcare Group’s previous dividend of $1.30.
In other news, insider Justin Ash purchased 46,500 shares of the stock in a transaction dated Tuesday, March 6th. The stock was acquired at an average cost of GBX 215 ($3.02) per share, for a total transaction of £99,975 ($140,335.49).
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/04/spire-healthcare-group-spi-sets-new-52-week-low-at-204-80.html.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgeries, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat problems; and eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart diseases, and kidney disorders.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.